Covid-19 vaccines saved 20 million lives in 2021: study

The launch of the vaccines against Covid-19 they were a significant turning point in the pandemic, and rightly so, new research has revealed.

A study published in the journal Lancet Infectious Diseases estimates that nearly 20 million lives were saved in just one year thanks to vaccines against the virus. coronavirus.

The first puncture was given to 91-year-old Maggie Keenan on December 8, 2020, in the UK, followed by 81-year-old Bill Shakespeare.

The UK was about to enter another wave of infections, but the vaccination program seemed to be the light at the end of the tunnel.

Covid-19 vaccines prevented almost 20 million deaths

Covid-19 vaccines prevented almost 20 million deaths. Many more deaths from Covid-19 could have been prevented.

Academics at Imperial College London analyzed data from 185 countries and found that 19.8 million deaths were averted in the first year of the vaccine’s launch alone, between December 2020 and December 2021.

John Hopkins University in the US believes that around 6.3 million people have died from covid worldwide since the start of the pandemic, while there have been more than 540 million cases of the virus in all the world.

As we have mentioned in AmericanPost.Newsabout 11.6 billion vaccines have been delivered worldwide.

The authors explained: “Covid-19 vaccination has substantially altered the course of the pandemic, saving tens of millions of lives worldwide.”

Dr. Oliver Watson, lead author of the study, said this is evidence of the “remarkable global impact” the vaccination program had.

It added: “Of the nearly 20 million deaths estimated to have been averted in the first year after the introduction of vaccines, nearly 7.5 million deaths were averted in the countries covered by the Access to Covid Vaccine initiative. -19 (Covax)”.

This program promoted equity in vaccines around the world, regardless of a person’s wealth or their country of origin. At least two-thirds of the world’s population are believed to have received at least one injection.

Many more Covid-19 deaths could have been prevented

Many more deaths from Covid-19 could have been prevented.

The researchers concluded that the majority of deaths averted occurred in wealthy countries, estimating that 12.2 million of the lives saved occurred in high- and upper-middle-income countries.

The document also suggested that an additional 600,000 deaths could have been prevented if World Health Organization (WHO) vaccination targets, which target 40% of each country’s population by the end of 2021, had been met.

Many countries already missed the goal of vaccinating 10% of their population last September. The WHO has stated: “The virus is moving faster than the global distribution of vaccines.”

He adds that if the doses had been distributed equally, there would have been enough for all healthcare workers and older people globally.

Dr Watson explained: “More could have been done. If the targets set by the WHO had been achieved, we estimate that about one in five of the lives lost to Covid-19 in low-income countries could have been prevented.”

The paper’s authors also wrote: “Inadequate access to vaccines in low-income countries has limited impact in these settings, reinforcing the need for global equity and vaccine coverage.”

This still does not mean that the pandemic is over. far from there A recent increase in cases of the Omicron subvariants, BA.4 and BA.5, has raised new concerns that the vaccine’s efficacy is declining.

It’s been around six months since the government promoted the booster launch program to stem a wave of Omicron in the UK, and Covid cases are rising for the first time since March.

The new strains have also sparked renewed debate about whether they can attack lung cells, like the previously dominant Alpha and Delta variants, potentially triggering another resurgence of infections.

This is particularly concerning because, although the initial Omicron strain was significantly more transmissible, it triggered less severe symptoms and was less likely to trigger prolonged covid.

However, scientists are working on specialized vaccines against covid. Moderna is now testing a two-in-one prick that should produce “very high levels of antibodies.”

The company’s chief medical officer, Dr. Paul Burton, said he was confident this “will translate into clinical protection against infection for anyone in the Omicron family.”

Follow us on Google News, Facebook and Twitter to stay informed with today’s news!